Absence of Macrolide-Resistant Mutations in <i>Bordetella pertussis</i> in Antananarivo (Madagascar) and Cambodia During the Last Pertussis Cycle Before the COVID-19 Pandemic
Macrolides are the first-line treatment against pertussis. The high prevalence of macrolide-resistant <i>Bordetella pertussis</i> (MRBP) strains reported in China is concerning. MBRP might be underestimated in other countries. Looking for the mutation causative for MRBP in retrospective studies conducted in Madagascar and Cambodia, we found no MRBP.
Authors
- Florence Campana (ORCID: https://orcid.org/0000-0002-1048-1771)
- Lala Rafetrarivony
- Mallorie Hidé (ORCID: https://orcid.org/0000-0001-5364-3032)
- Mohand Ait‐Ahmed
- Laurence Borand (ORCID: https://orcid.org/0000-0001-7431-5900)
- Fabien Taieb (ORCID: https://orcid.org/0000-0002-0941-2859)
- Aina Harimanana (ORCID: https://orcid.org/0000-0001-6690-2945)
- Nicole Guiso (ORCID: https://orcid.org/0000-0001-5163-4028)
- Jean‐Marc Collard (ORCID: https://orcid.org/0000-0002-1490-3978)
- Gauthier Delvallez (ORCID: https://orcid.org/0000-0002-5490-4238)
- Gaëlle Noël (ORCID: https://orcid.org/0000-0003-3422-489X)
- Shi Han (ORCID: https://orcid.org/0000-0003-1661-3680)
- Mahdi Rajabizadeh
Institutions
- Johns Hopkins University (US)
- Institut Pasteur (FR)
- Johns Hopkins Medicine (US)
- Institut Pasteur de Madagascar (MG)
- Institut Pasteur du Cambodge (KH)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-09-12
- DOI
- https://doi.org/10.1093/ofid/ofaf566
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 0.00